QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 

   

 

Health Affairs, 25, no. 4 (2006): w262-w271
(Published online 6 June 2006)
doi: 10.1377/hlthaff.25.w262
© 2006 by Project HOPE
 
New Online
 * How Would Obama, McCain Cover The Uninsured?
 * Debating Cost Of Uninsured
 * Try Medicare-For-All
 * HA Blog Top 10
This Article
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* View responses
* Alert me when this article is cited
* Alert me when eLetters are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Neumann, P. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Neumann, P. J.
Related Collections
* Access To Care
* Consumer Issues
* Evidence-Based Medicine
* Health Reform
* Insurance Coverage
* Managed Care - Medicaid
* Medicaid
* Pharmaceuticals
* State/Local Issues

Web Exclusives

Emerging Lessons From The Drug Effectiveness Review Project

Peter J. Neumann

The Drug Effectiveness Review Project (DERP) is an alliance of fifteen states and two private organizations, which have pooled resources to synthesize and judge clinical evidence for drug-class reviews. The experience shines a bright light on challenges involved in implementing an evidence-based medicine process to inform drug formulary decisions: When should evidence reviewers accept surrogate markers and assume therapeutic class effects? How open and participatory should review procedures be? Should reviewers consider cost-effectiveness information? What is the appropriate role of the public sector in judging evidence? The DERP illustrates that attempts to undertake evidence-based reviews, apart from the methods themselves, which continue to evolve, involve questions of organization, process, and leadership.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
Health Aff (Millwood)Home page
W. F. Stewart, N. R. Shah, M. J. Selna, R. A. Paulus, and J. M. Walker
Bridging The Inferential Gap: The Electronic Health Record And Clinical Evidence
Health Aff., March 1, 2007; 26(2): w181 - w191.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
S. D. Findlay
Bringing The DERP To Consumers: 'Consumer Reports Best Buy Drugs'
Health Aff., July 1, 2006; 25(4): W283 - W286.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

DERP Compared to What?
Ramon Castellblanch
Health Affairs, 9 Jun 2006 [Full text]
Balancing Individual Needs With Scientific Evidence
Jennifer L. Bright
Health Affairs, 1 Aug 2006 [Full text]


Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help

© 2001-2006 Project HOPE–The People-to-People Organization
Terms and Policies